Migraine is a debilitating neurological disease, ranking consistently among the top 10 leading causes of years lived with disability, worldwide. The main symptom of migraine is an enduring headache, along with symptoms such as severe pain on one side of the head or throbbing pain, sensitivity to light and sound, and nausea. Despite being a very common headache disorder that affects roughly 15 percent of the adult population worldwide, it remains inadequately understood and most neglected.
In Delhi, approximately 25 per cent of the population suffers from migraines, every year.
While migraine is an invisible condition, it can severely impact individuals across personal, professional and social domains, thus affecting the overall quality of life and productivity. Work-from-home, or the 'new normal,' has drastically impacted the lives of people suffering from migraines from an inability to concentrate at work to missed workdays. It has become even more urgent to ensure that individuals have the understanding and tools to effectively manage migraines.
There is a lack of understanding amongst people about the severity of migraines. In a study we recently conducted, about 50 to 60 per cent of migraineurs were undiagnosed, despite recurrent headaches. Because migraine falls on a spectrum, ranging from infrequent or mild attacks to recurrent ones, many pass it off as merely a headache'. With busy work-from-home schedules, paired with fear of contracting COVID-19 infection and difficulty in accessing in-person care, people are avoiding seeking medical help for the condition, instead attributing symptoms to associated comorbidities, such as stress or depression."
He continued, "Financial worries due to job loss or salary cuts also contribute to aggravated migraine attacks, which is more noticeable recently. The effects of migraine on one's quality of life also reportedly worsened, particularly for many migraineurs working as essential healthcare workers at this time.
Symptom neglect and failure to treat the condition can lead to migraines becoming chronic. A fundamental need is to recognize migraine as a serious condition with severe disability and adopt a holistic treatment approach. Early detection can be a key enabler of a smoother patient journey and an improved quality of life."
Here are 5 ways to manage your migraine while working from home:
Identify Risk Factors and Monitor Triggers
Migraines can begin at any age but tend to peak during one's prime productive years. Moreover, women are three times more likely to be affected than men, with prevalence peaking between the ages of 25 and 55 years.
Long hours of working from home, along with longer screen times, disrupted sleep schedules and irregular eating habits can increase stress levels. For migraineurs, such changes can become migraine triggers, exacerbating their condition. Identifying personal triggers can help individuals manage their migraines better.
Make The Right Choice for Diet and Lifestyle
Working from home can be hard, but a daily routine that optimizes your physical and mental health can help keep your migraine at bay. Eating healthy meals at appropriate times or consuming small, frequent meals throughout the day are associated with less frequent migraine headaches. Taking breaks from work at regular intervals can help you eat right and reduce eye strain owing to excessive screen use. Making modifications to your lifestyle, including smoking cessation and reduced alcohol consumption, and maintaining optimal sleeping habits and exercising regularly can be key to manage migraines. These also benefit migraine prevention and treatment.
Talk to An Expert
It is important to consult a medical specialist when you are experiencing severe headaches that disrupt your daily routine. A lot of migraineurs hesitate to seek medical help. This could be due to several reasons lack of understanding of migraine severity, lack of time due to hectic work-from-home schedules, or recently, due to a reduction in-person clinic consultations owing to the fear of Covid-19 infection. However, consulting a neurologist, even via teleconsultations, is a necessary step to diagnose your condition and understand the available options for acute and chronic management of migraine, including preventive treatment. With evidence-based information on effects across migraine intensity reduction, quality of life and ease of use, neurologists can guide you on the most suitable treatment option to prevent or reduce your migraine episodes.
Track Your Migraines
It is a good idea to maintain a diary (or download a migraine tracker app), to record the time and severity of your migraine attacks, symptoms, daily diet, exercise routines, and medications and side effects. This can help identify triggers and patterns. It can also prompt meaningful conversations with your doctor, contributing to a more holistic treatment plan, personalized to suit your work schedule.
Seek Support From Your Family, Friends or Colleagues
Living with migraines can make one feel helpless, distressed and misunderstood. But talking to your friends and family will help them understand your condition better. Having an open conversation about your migraine with your employer is a good idea, particularly to work out a schedule, with specific routine adjustments to mitigate triggers. This can help you be productive and healthy while working from home. Employers can also take the initiative -- arranging wellness programs for employees to raise awareness about migraines and how to effectively manage them at work and enhance productivity.
Migraine attacks can be challenging. Changes to your daily routine and active communication about your condition with your employer, after consulting a neurologist, can help you better manage migraines as you work from home.
Read More► The Best Ways to Treat A Sun Tan?
Washington, July 13 (IANS) The US Food and Drug Administration (FDA) added a new warning on the Johnson & Johnson Covid-19 vaccine, saying the jabhas been linked to a serious but rare side effect called Guillain-Barre syndrome.Guillain Barre syndrome is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis, Xinhua news agency reported citing the FDA as saying.The syndrome has occurred in some people who have received the Johnson & Johnson vaccine, the FDA in a letter on Monday. In most of these people, symptoms began within 42 days following injections of the vaccine, it added.The chance of having this occur is very low, the agency said.About 100 preliminary reports of Guillain-Barre syndrome have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson jab in the US, The Washington Post quoted the Centers for Disease Control and Prevention (CDC) as saying in a statement.Of these reports, 95 were serious and required hospitalization, and one had dead.The cases have largely been reported about two weeks after vaccination and mostly in men, many aged 50 and older, according to the CDC.Johnson & Johnson said on Monday it has been in discussions with the FDA and other regulators about rare cases of Guillain-Barre syndrome.The chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree, the company said in a statement. --IANSksk/
New Delhi, July 5 (IANS) A team of doctors at BLK-Max Super Speciality Hospital, here, has saved the life of a newborn boy by successfully treating him for a rare congenital heart condition.The newborn boy had aortic stenosis (narrow heart valve), which was treated successfully using balloon dilation technique by a minimally invasive procedure. While the procedure has been performed on infants before, the condition is rare in new-borns since it is mainly age-related, making this one of the first cases in India done on a 2-day-old neonate, the doctors said.Aortic stenosis is a term used to describe congenital heart defects that obstruct blood flow from the heart to the body. Significant aortic stenosis is relatively uncommon, affecting about six of every 1,000 babies born, occurring more often in boys."The neonate was referred to us with the diagnosis of mild aortic valve stenosis in "shock" (poor respiratory effort with poor perfusion of the body with decreased urine output). He was gasping for breath with poor perfusion of the body. On examination, we found that his breathing was fast with signs of shock and decreased urine output," said Subhash Chandra, Chairman and HOD, Cardiology BLK-Max Super Speciality Hospital, in a statement."The echocardiogram showed deformed aortic valve with critical narrowing of the valve and very poor heart pumping. At once, we counselled the distressed family about the procedure and went ahead with it immediately," he added.In balloon dilation, cardiac catheterisation is done by inserting a tube, also known as a catheter into a blood vessel in the groin, which is then guided towards the heart of the patient. The catheter contains a deflated balloon on its tip. Once it is placed in the narrow valve of the heart, the balloon is inflated to stretch the valve open.Despite the procedure, there were still some issues that were impeding healthy recovery."Post the procedure, the baby was shifted to NICU for monitoring, however, there was still no pulse in his left leg. We decided to continue the patient on medicines and fortunately after around three hours, his pulse returned. We extubated the baby the next day as he was showing stable vitals. He was discharged the very next day with a well-opened narrow valve and near normal pumping of the heart," Chandra said.--IANSrvt/dpb
New Delhi, June 22 (IANS) Eleven individuals who received the AstraZeneca-Oxford Covid-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported in two separate studies.The studies, published in the peer-reviewed medical journal Annals of Neurology, describe an unusual variant of Guillain-Barre syndrome characterised by prominent facial weakness. All the eleven cases were among people who had received that vaccine 10-22 days earlier.Seven cases were reported from a regional medical center in Kerala, India, where approximately 1.2 million people were vaccinated with the AstraZeneca Covid-19 vaccine till April 22. The cases occurred within two weeks of the first dose of vaccination."Six out of the seven patients progressed to areflexic quadriplegia and required mechanical ventilatory support," said Boby Varkey Maramattom, from the Department of Neurology, Aster Medcity, Kochi, Kerala."The frequency of GBS was 1.4 to 10 fold higher than that expected in this period for a population of this magnitude. In addition, the frequency of bilateral facial weakness, which typically occurs in less than 20 per cent of GBS cases, suggests a pattern associated with the vaccination," he added.Four cases were reported from Nottingham, England, in which approximately 700,000 people received the same vaccine. These were characterised by bifacial weakness with a paraesthesias variant of GBS occurring within three weeks of vaccination with the Oxford-AstraZeneca SARS-CoV-2 vaccine."This rare neurological syndrome has previously been reported in association with SARS-CoV-2 infection itself. Our cases were given either intravenous immunoglobulin, oral steroids, or no treatment," said Jonathan Rhys Evans, Department of Neurology, Nottingham University Hospitals NHS Trust, UK."If the link is causal it could be due to a cross-reactive immune response to the SARS-CoV-2 spike protein and components of the peripheral immune system," wrote the authors of the report from England.While the benefits of vaccination substantially outweigh the risk of this relatively rare outcome (5.8 per million), the research groups stressed that clinicians should be alert to this possible adverse event and look for this rare neurological syndrome following administration of Covid-19 vaccines."We suggest vigilance for cases of bifacial weakness with paraesthesias variant GBS following vaccination for SARS-CoV-2 and that post-vaccination surveillance programmes ensure robust data capture of this outcome, to assess for causality," Evans said.--IANSrvt/dpb
Chandigarh, June 12 (IANS) Legendary athlete Milkha Singh, who is being treated for Covid related complications at the PGIMER here, has shown improvement in his health conditions, the hospital said on Saturday."Milkha Singh's health is fine and improving, but he is still in the ICU (Intensive Care Unit)," said a spokesperson for the Post Graduate Institute of Medical Education and Research (PGIMER).Milkha Singh has been under the observation of a medical team comprising senior doctors of the institute since his hospitalisation on June 3.Earlier, Milkha Singh, 91, was admitted to the Fortis Hospital in Mohali near here after testing positive for the virus.He was discharged from Fortis, but had to be taken to PGIMER after he complained of low oxygen level.His wife Nirmal Kaur, 82, is also undergoing treatment for Covid-19 at the Fortis Hospital.--IANSvg/arm
Lucknow, April 18 (IANS) Uttar Pradesh Chief Minister Yogi Adityanath, who was tested positive for Covid is improving in home isolation.According to official sources, the Chief Minister's condition is being closely monitored by doctors and he does not have a fever now. His oxygen levels are also normal.The Chief Minister is observing Navratri fast for nine days and is holding virtual meetings with officials to monitor the Covid situation in the state.Yogi Adityanath had announced that he was isolating himself on Tuesday after a number of officials in his secretariat tested positive for Covid.The Chief Minister also tested positive for Covid on Wednesday but was mainly asymptomatic.--IANSamita/dpb